National trends in utilization of thrombolytic therapy for acute pulmonary embolism

Vasc Med. 2022 Feb;27(1):75-76. doi: 10.1177/1358863X211048544. Epub 2021 Oct 26.

Sebastian E Beyer¹, Colby Shanafelt¹, Duane S Pinto², Jeffrey L Weinstein³, Jay Giri⁴, Akhilesh K Sista⁵, Robert W Yeh^{2

6}, Eric A Secemsky^{2

6}, Brett J Carroll^{2

6}

¹ Division of Cardiology, Weill Cornell Medical College, New York-Presbyterian Hospital, Weill Cornell Medical Center New York City, New York, USA.
² Division of Cardiovascular Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
³ Division of Interventional Radiology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁴ Department of Medicine, Cardiovascular Medicine Division, Penn's Cardiovascular Outcomes, Quality, and Evaluative Research (CAVOQER) Center, University of Pennsylvania, Philadelphia, PA, USA.
⁵ Department of Radiology, New York University School of Medicine, New York, NY, USA.
⁶ Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

No abstract available

Keywords: catheter-directed treatment; pulmonary embolism (PE); thrombolysis.

MeSH terms